Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Is It Our Responsibility to Educate Others About CF? MS1819-SD Shows Positive Results for Exocrine Pancreatic Insufficiency in Phase 2a Trial Is It Our Responsibility to Educate Others About CF? Oct 01, 2018 09:00 am | Tré LaRosa I’ve noticed that there are two schools of thought in the CF community about discussing our life with a chronic disease. The first: If we expect others to be considerate and respectful of our circumstances, we must educate them about the intricacies of life with CF. The other: It’s not our responsibility to divulge our […] The post Is It Our Responsibility to Educate Others About CF? appeared first on Cystic Fibrosis News Today. Read More MS1819-SD Shows Positive Results for Exocrine Pancreatic Insufficiency in Phase 2a Trial Oct 01, 2018 07:00 am | Iqra Mumal AzurRx BioPharma, in partnership with Mayoly Spindler, announced that a recent Phase 2a clinical trial testing MS1819-SD as a potential treatment for exocrine pancreatic insufficiency (EPI) achieved its goals, namely a statistically significant improvement in fat absorption. EPI, often caused by cystic fibrosis, is a disease resulting from a lack of exocrine pancreatic enzymes, which play […] The post MS1819-SD Shows Positive Results for Exocrine Pancreatic Insufficiency in Phase 2a Trial appeared first on Cystic Fibrosis News Today. Read More   Recent News In Memory of Serena Lawrence, Who Inspired Voices of the Hurting and Sick #NACFC2018 — Sound Pharmaceuticals to Present Preliminary Data on Ototoxicity Study Vivus Lends Support to CFF Dallas, Forth Worth Chapters’ Recent CF Climb Fundraiser Data Promising on Nitric Oxide as Treatment Against Mycobacterium abscessus, AIT Reports Cases of Injustices, Humiliations, and Sorrows